| General Information | |||
|---|---|---|---|
| Term | systemic scleroderma | ID (Ontology) | DOID:418 (Human Disease) |
| Definition | A scleroderma that is characterized by fibrosis (or hardening) of the skin and major organs, as well as vascular alterations, and autoantibodies." [url:https\://ghr.nlm.nih.gov/condition/systemic-scleroderma] {comment="sn:IEDB"} | ||
| Also Known As | "progressive systemic sclerosis" ; "Scleroderma" ; "Scleroderma syndrome" (for all, see Synonyms field below) | ||
| Comment | |||
| Links to External Ontologies | |||
| DO.org | |||
| Annotations | |||
| Records annotated with this term OR any of its CHILD TERMS | |||
Full annotation statements including this term (annotations to child terms are NOT included), and relevant FlyBase records
|
|||
|
||||||
rheumatic disease |__scleroderma |__systemic scleroderma |__diffuse scleroderma |__limited scleroderma |__pulmonary systemic sclerosis |
| Spanning Tree View Settings | |||
|---|---|---|---|
| Parents/Children View Depth |
|||
Relationships
|
|||
| Is a | scleroderma | ||
| Part of | |||
Synonyms & Secondary IDs
|
|||
| Synonyms | |||
|
|||
| Secondary IDs | |||
|
|
|||
External Crossreferences & Linkouts
|
|||
|
EFO:0000717 GARD:9748 ICD10CM:M34.0 ICD9CM:710.1 MESH:D012595 MIM:181750 NCI:C72070 SNOMEDCT_US_2023_03_01:89155008 UMLS_CUI:C0036421 |
|||